This project has developed a self-report risk assessment tool to assess risk of developing late-life Alzheimer’s disease. The project used an evidence based medicine approach drawing from meta-analyses and high quality cohort studies. A website for this ANU-ADRI is in development. The ANU-ADRI is currently being used in the BBL project as an outcome measure and is being cross-validated for Mild Cognitive Impairment.
Please visit the Alzheimer's Disease Risk Index website for more information.